|Year : 2022 | Volume
| Issue : 1 | Page : 6-13
The diverse role of oral fibroblasts in normal and disease
RJ Vijayashree1, B Sivapathasundharam2
1 Department of Oral Pathology and Microbiology, Meenakshi Ammal Dental College and Hospital, Chennai, Tamil Nadu, India
2 Department of Oral Pathology and Microbiology, Priyadharshini Dental College and Hospital, Tiruvallur, Tamil Nadu, India
|Date of Submission||28-Jan-2022|
|Date of Decision||03-Feb-2022|
|Date of Acceptance||03-Feb-2022|
|Date of Web Publication||31-Mar-2022|
R J Vijayashree
Department of Oral Pathology and Microbiology, Meenakshi Ammal Dental College and Hospital, Alappakkam Main Road, Maduravoyal, Chennai - 600 095, Tamil Nadu
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Fibroblasts are the major cellular component of the connective tissue. They differ both structurally and functionally based on their location. The oral fibroblasts vary from the dermal fibroblasts in their origin, properties and also functions. These cells play an important role in wound healing, tumor progression and metastasis, allergic reactions. In this review, the various functions of the oral fibroblasts are discussed in detail.
Keywords: Cancer-associated fibroblasts, fibroblasts, healing, myofibroblasts, oral fibroblasts, oral submucous fibrosis
|How to cite this article:|
Vijayashree R J, Sivapathasundharam B. The diverse role of oral fibroblasts in normal and disease. J Oral Maxillofac Pathol 2022;26:6-13
|How to cite this URL:|
Vijayashree R J, Sivapathasundharam B. The diverse role of oral fibroblasts in normal and disease. J Oral Maxillofac Pathol [serial online] 2022 [cited 2022 Aug 17];26:6-13. Available from: https://www.jomfp.in/text.asp?2022/26/1/6/341415
| Introduction|| |
Virchow (circa 1858) and later Duvall studied cells in the connective tissue using classic anatomy techniques and microscopy. The fibroblasts were then defined as cells in the connective tissue that synthesize collagen. Fibroblasts are found in almost every organ and tissue of the body. They are morphologically and functionally heterogeneous in nature. Even within the same tissue, they differ based on their location. For example, the dermal fibroblasts are called papillary fibroblasts (Fps), reticular fibroblasts (Frs) and dermal-subcutaneous junction fibroblasts (F-DHJs) based on their location. The Fps are tricuspid in shape and arranged close to each other. The Frs are stellate in shape and loosely arranged, whereas the F-DHJs are morphologically uneven.
| Fibroblasts Origin|| |
The head and neck fibroblasts arise from the neural crest-derived ectomesenchyme during development. The fibroblasts of other issues arise from the primary mesoderm. They also arise through the epithelial-mesenchymal transition in organs like the liver, kidney; through the endothelial-mesenchymal transition in lungs, heart and also from circulating cells such as mesenchymal stromal cells or fibrocytes.
| Structure of Fibroblasts|| |
Within a tissue, the fibroblasts exist in either of the two states – active or quiescent. The active fibroblasts are large, ovoid with abundant basophilic cytoplasm and a pale staining nucleus. They have a prominent nucleolus, well-developed Golgi complex, abundant rough endoplasmic reticulum, secretory granules and numerous mitochondria. In adults, rarely undergo mitosis. The quiescent fibroblasts, also called fibrocyte, are small, spindle-shaped with acidophilic cytoplasm and a small, dark elongated nucleus. The nucleolus is not present. They contain fewer processes and less rough endoplasmic reticulum. Upon adequate stimulation, the fibrocyte can revert to the active fibroblast state and acquire synthetic functions.,
Fibroblasts usually lack intercellular junctions. However, the exceptions being, in embryonic tissue they show gap junctions, in periodontal tissue they show gap junctions and cell to cell contact of adherents type, and in the dental pulp tissue they are attached by desmosomal junctions. Fibronexus are the focal contacts formed between the fibroblasts and the extracellular matrix components., Fibroblasts also exhibit planar polarity and cell plasticity.
The fibroblasts lack epithelial, vascular and leukocyte lineage markers. They express cell surface markers Cq-1, CD 40, CD 39, Thy-1 and CD 90.,, Upon activation CD 90 regulates the proliferation and differentiation of fibroblasts. They also express pattern recognition receptors like Toll-like receptors and also possess chemokine receptors., The cancer-associated fibroblasts (CAFs) express CD 44, CD 49b, CD 87, CD 95 and Ly-6C. The pro-tumorigenesis markers are Fibroblast-activation protein, Platelet-derived growth factor (PDGF) Rα/β, podoplanin (PDPN), CD 70, vimentin, G-protein coupled receptor (GPR) 77, CD 10 and CD 74. The tumor suppressive biomarkers are CD 146, CAV1, Saa3−.
| Derivatives of Fibroblasts|| |
The fibroblasts are the cells of the connective tissue. They secrete collagen, proteoglycans, glycosaminoglycans, glycoproteins, prostaglandins, matrix metalloproteinases, some cytokines and growth factors. The proteoglycans are the decorin and aggrecan. The glycosaminoglycans are the hyaluronic acid, chondroitin sulfate, dermatan sulfate, heparan sulfate and keratan sulfate. The glycoproteins namely fibronectin, laminin, entactin, and tenascin.
The collagen fibers are inelastic, constituting approximately 25% of the total body protein. They resist tensile forces and are of approximately 27 different types. The fibroblasts are the major source of collagen. They synthesize and degrade collagen. Intracellular degradation of collagen by fibroblasts is mediated through MMPs (Matrixmetallopreoteinases) and is the important mechanism for physiologic turnover and remodeling. The fibrils are recognized by the fibroblast integrin receptor. Gelatinase A (MMP-2) partially digests the fibrils. The lysosomal enzyme cathepsin further degrades the fibrils within the phagolysosome.,
| Mesenchymal Stem Cell-Like Properties of Fibroblasts|| |
Human fibroblasts possess certain phenotypic and immunologic characteristics similar to human mesenchymal stem cells. The fibroblasts from foreskin, lung and mammary tissue are known to express cell surface markers such as CD 73, CD 70, CD 105, CD 29 and CD 44 similar to the mesenchymal stem cells from bone marrow and adipose tissue. They also possess the ability to differentiate into adipocytes, chondrocytes and osteoblasts similar to mesenchymal stem cells. The immunologic characteristics such as the ability to suppress T-cell proliferation, modulate immunophenotype of macrophages and to express Human Leukocyte Antigen– DR isotype upon stimulation with Interferon-gamma are expressed similar to the mesenchymal stem cells.
Upon laterally confined growth on micropatterned substrates, stem cell-like properties confer on fibroblasts. Embedding these cells into collagen-1 matrices of varying densities, mimicking different three-dimensional tissue constrains, the cells regain back their fibroblastic properties. They begin to exhibit features of reduced DNA damage, enhanced cytoskeletal gene expression, enhanced actomyosin contractility, increased matrix deposition and collagen remodeling. Therefore, the fibroblasts rejuvenation can also find its place in regenerative medicine.
| Fibroblasts in Normal Oral Tissues|| |
Fibroblasts play an important role in all the oral tissues. Collagen, the major secretory protein of fibroblasts, is the important component of the extracellular matrix of oral tissues such as dentin, cementum, bone, oral mucosa and salivary glands. Microscopically, the fibroblasts of all tissues appear similar. However, they vary between different connective tissue and also within the same connective tissue both in structure and function.
| Dental Pulp Fibroblasts|| |
The fibroblasts are the principal cell type in the dental pulp. They are numerous in the cell-rich zone of the dental pulp and have their origin from the undifferentiated ectomesenchymal cells. They synthesize and secrete collagen and ground substance. The pulp fibroblasts function as immune and inflammatory cell. They are capable of producing pro-inflammatory cytokines and can express adhesion molecules. They synthesize Interleukin (IL)-8, IL-6 and express several Toll-like receptors and Nucleotide-Binding Oligomerisation Domains. Human dental pulp fibroblasts have an important role in pulp healing following pulpal injury. They express various growth factors, such as fibroblast growth factor-2 (FGF-2) and Vascular endothelial growth factor-2 (VEGF-2) and thus help in angiogenesis, revascularization, nerve-sprouting and regeneration of dentin-pulp complex.
The human dental pulp fibroblasts, in the presence of Gram-positive organisms and upon stimulation by Lipoteichoic acid, produce complement components that in turn activate the complement cascade with the formation of Membrane Attack Complex and generate C5a. The C5a activate the C5aR expression by Pulp progenitor cells and also induce their gradient-dependent migration. Thus, a nonimmune, nonhepatic cell, the pulp fibroblasts, can synthesize complement components.,
| Periodontal Ligament Fibroblasts|| |
The periodontal ligament (PDL) fibroblasts exhibit a high turnover rate. The periodontal fibroblasts have the capacity for osteogenic, adipogenic and neurogenic differentiation in vitro when there is ectopic expression of human Telomerase reverse transcriptase and Bone morphogenic protein-4 (BMP-4). They express osteoblasts-like characteristics and osteogenic potential when cultured in vitro. They also show cementum/PDL-like tissue regeneration in vivo. They express osteocalcin, Runxz and periostin.,, These fibroblasts influence alveolar bone remodeling through Osteoprotegerin-Receptor activator of nuclear factor kappa-B ligand (RANKL) pathway and also can alter inappropriate mineralization such as during root ankylosis. They also exhibit the property of contractility that is vital during tooth eruption. The human PDL fibroblasts can also be used as a source for induced pluripotent stem cells (iPSCs) under optimum conditions. PDL fibroblasts acquire myofibroblasts like property during wound healing. Fibroblast contractility plays an important role in posteruptive tooth movement.
Age is an important factor determining the cellular activity of gingival fibroblasts in relation to viability, total protein production and collagen synthesis. All these properties reduce with age. 1 cm3 of gingival connective tissue has about 200 million fibroblasts that is 5% in volume.
| Oral Mucosal Fibroblasts|| |
When compared to the dermal fibroblasts, the proliferating capacity of oral mucosal fibroblasts is more. Also, when exposed to Transforming growth factor-β1 (TGF-β1), the oral mucosal fibroblasts synthesize more collagen. In regards to the healing characteristics, the oral mucosal fibroblasts exhibit fetal-tissue like phenotype. The iPSCs can be generated from oral mucosal fibroblasts and the fibroblasts can be considered a potential cellular source for regenerative dentistry/medicine.
| Bone Fibroblasts|| |
The fibroblasts situated in the perivascular and endosteal location, when appropriately stimulated, results in the formation of bone, PDL and cementum.
| Wound Healing and Fibroblasts|| |
The process of wound healing is different in the skin and oral mucosa. Oral mucosal wounds heal faster and also the formation of hypertrophic scars is rare in oral mucosa, compared to dermal wounds. The probable reason might be the difference in the keratinocyte and fibroblast properties in the two tissues.
In the skin, the fibroblasts enhance the migration and proliferation of the keratinocytes in a time and density-dependent manner., The oral keratinocytes proliferate faster than the dermal keratinocytes. However, in both the tissues, the keratinocyte proliferation is influenced by the underlying fibroblasts. Furthermore, the oral fibroblast proliferation rate is greater than the dermal fibroblasts and their doubling time is comparatively less. These cells stop proliferating as they grow to confluent in culture, while the dermal fibroblasts continue proliferation – a probable explanation for rare hypertrophic scar in oral mucosa.
The oral and dermal fibroblasts express similar growth factors but in varying proportions. Buccal mucosal fibroblasts show increased secretion of Keratinocyte growth factor (KGF) and Hepatocyte growth factor (HGF) with an increase in the expression of KGF mRNA and HGF mRNA than the dermal fibroblasts. KGF stimulates re-epithelialization in a paracrine manner. The inflammatory mediators IL-19, IL-20, IL-1 β, IL-6, Tumor Necrosis Factor-alpha (TNF-α) stimulate the expression of KGF in fibroblasts. KGF in turn enhances keratinocyte proliferation. HGF stimulates fibroblasts to produce MMP-1 and also inhibits the expression of TGF-β. Therefore, HGF prevents fibrosis. Thus, increased expression of KGF and HGF in oral fibroblasts is responsible for faster and scarless healing of oral mucosa.
Dermal wound in mice when treated with human gingival fibroblasts and human gingival fibroblasts – conditioned medium, reduce inflammation, enhance angiogenesis and increase collagen deposition. The net result is faster wound closure. The neutrophils and macrophages at the wound site reduce and the macrophages polarize towards an anti-inflammatory phenotype. Furthermore, the anti-inflammatory cytokine IL-10 increases and the pro-inflammatory cytokine TNF-α reduce. There is also enhanced proliferation of Human Dermal Microvascular Endothelial Cells to form vessel-like structures.
The gingival fibroblasts also express α-actin and microfilaments, suggestive of a myofibroblastic phenotype of the gingival fibroblasts. They exhibit an efficient synthesis of Type III collagen, fibrillin, MMP-2, MMP-9 and Tissue inhibitor of metalloproteinase-2 (TIMP-2).
Oral fibroblasts promote the differentiation of oral keratinocytes. The fibroblasts inhibit spontaneous cell death of the basal layer of the epithelium. The suprabasal layer expresses more CK13 and less CK 14 and CK 19. The fibroblasts also enhance terminal differentiation of the superficial layer and increase the apoptotic rate. The synthesis of the basement membrane components such as laminin and Type IV collagen at the epithelial-collagen biomatrix are also enhanced by the fibroblasts.
Periodontal wound healing is a complex process since it involves the cross-talk between connective tissues, of both hard and soft tissue, as well as the epithelium. The PDL fibroblasts are involved in maintaining and remodeling of the PDL, cementum and the hard tissue, the bone. It is only the PDL fibroblasts that can create new connective tissue attachment to the root surface. Furthermore, these fibroblasts exhibit osteoblasts-like properties. They also synthesize more alkaline phosphatase than gingival fibroblasts. They can synthesize mineralized structures.
After tooth extraction, there is clot formation followed by an inflammatory phase. The PDL fibroblasts then migrate to the extraction socket. The proliferation phase is marked by the proliferation of fibroblasts. The proliferation rate increases 24 h after extraction. They assume a synthetic phenotype marked by increased cellular organelles. At 3rd day, the blood clot undergoes coagulative necrosis and the coagulum is replaced by dense connective tissue later. The PDL fibroblasts differentiate into osteoblasts at around 5th day postextraction. TGF-β and FGF-2 are the important mediators of fibroblasts activation and proliferation. The endosteal and paravascular fibroblasts proliferate at a slower rate and at a later stage than the PDL fibroblasts.,
| Wound Contraction and Wound Strength|| |
Wound contraction depends on Rho-dependent kinase (ROCK). Lysophosphatidic acid acts on fibroblasts through GPR. This in turn activates GTPase, RhoA and ROCK, resulting in assembling of actin filaments. Thus initiates wound contraction.
Wound strength mainly depends on Type I collagen and the principal source of Type I collagen are the fibroblasts. After injury, platelets are activated. The activated platelets secrete PDGF. PDGF in turn activates the fibroblasts. The activated fibroblasts and macrophages secrete TGF-β, enhancing deposition of Type I collagen by fibroblasts. PDGF also acts as a potent mitogen for fibroblasts by activating the Mitogen-Activated Protein kinase and phosphatidyl inositol 3-kinase pathways via the PDGF receptor.,
| Fibroblasts in Oral Submucous Fibrosis|| |
Oral submucous fibrosis (OSMF) is a debilitating fibrotic disease. It involves fibrosis of the oral mucosa. The fibrosis is associated with arecanut chewing. The oral fibroblasts and their contribution in OSMF are largely explained through various studies.
The byproducts of arecanut are arecoline and arecaidine. Arecoline is cytotoxic and genotoxic to the oral fibroblasts. A high concentration of arecoline changes the fibroblasts more toward a senescent phenotype. The cells appear round with granular nucleus, scanty cytoplasm and cytoplasmic vacuoles. Also, the population doubling time increases and there is an increase in the number of postmitotic subpopulation of fibroblasts. There is repression of glutathione synthetase gene. Glutathione is a potent anti-oxidant. Arecaidine is a potent stimulator of fibroblast proliferation and collagen synthesis.,,,
The fibroblasts in OSMF synthesize more collagen and procollagen mRNA than normal oral fibroblasts. Also, the more resistant type I collagen trimer synthesis is increased.
In OSMF, the injury from arecanut chewing leads to synthesis of various inflammatory mediators and growth factors. There is an increase in the synthesis of basic FGF, connective tissue growth factor (CTGF), TGF-β, etc., Arecanut along with TGF-β increases the expression of pro-fibrotic growth factors such as CTGF, Fibronectin1, Endothelin1, collagen stabilizing and maturation genes, Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase 2, BMP 1, cytoskeletal reorganizing genes, LIM kinase-1, Transgelin, the transcriptional factors GATA binding factor-6, Early Growth Response-2 in oral fibroblasts. The growth factors are responsible for increased collagen fiber synthesis in OSMF. Also, the TGF-β enhances the transdifferentiation of fibroblasts to myofibroblasts. The myofibroblasts are α and γ-Smooth muscle actin (SMA) positive and may be the reason for persistence of fiber contraction in OSMF. Their number increases with severity of the disease.,,,,,
Arecoline augments TIMP-1 mRNA levels leading to increased accumulation of collagen fibers as TIMP is an inhibitor of MMP collagenases. The buccal mucosal fibroblasts contract in a dose and time-dependent manner, upon exposure to arecanut. The possible mechanism behind such contraction lies in the PLC/IP3/Ca2+/Calmodulin and Rhokinase signaling pathways and actin filament proliferation.,
| Cancer-Associated Fibroblasts|| |
The fibroblasts influence the tumor growth, invasion, progression and metastasis. They provide physical support for the tumor cells and also play a key role in promoting and retarding tumorigenesis in a context-dependent manner. The tumor microenvironment (TME) and the cancer cells influence each other and thus there exists a paracrine mechanism between the tumor cells and the stromal fibroblasts. The TME consists of both immune and nonimmune stromal cells. The fibroblasts are the predominant nonimmune stromal cells., They are called as CAFs, tumor-associated fibroblasts or activated myofibroblasts. The CAFs secrete various factors that influence the behavior and prognosis of the tumor. They are positive for α-SMA, S-100A4, nonnuclear GLI-1 (Glioma-associated oncogene homolog-1), TIMP-1.,,,,, The origin of these cells can be either the resident fibroblasts or the mesenchymal stem cells from the bone marrow or the oral squamous cell carcinomas (OSCC) cells that have undergone ectomesenchymal transition.
In breast cancer, the genes associated with cell death regulation, stress, hypoxia and carbohydrate metabolism are upregulated. The Tricarboxylic Acid cycle genes are upregulated. There is increased glucose uptake by the tumor cells and lactate is produced by these cells even in the presence of oxygen and functional mitochondria. This process of aerobic glycolysis is called the Warburg effect. The CAFs are more towards the Warburg effect. The lactate produced by the CAFs is utilized by the cancer cells as an adaptation mechanism. Also there is downregulation of genes involved in cell mitosis and cell membrane component synthesis.
There exists a bidirectional interaction between tumor cells and fibroblasts. TGF-β1 is produced by both the tumor cells and the CAFs. They transdifferentiate the normal oral fibroblasts to CAFs. They also up-regulate the PDPN expression of tumor cells, which in turn increase the synthesis of TGF-β1. The CAFs also activate the Protein kinase B/AKT, Epidermal growth factor receptor and Extracellular signal reductase kinase in OSCC, eventually increasing the OSCC proliferation and invasion.
The CAFs serve as an important source of Hedgehog (HH) ligands and respond to the HH signaling pathway through nuclear GLI-1 (Glioma-associated oncogene homolog-1) activation. The HH cascade involved in tumor initiation and progression are mediated through paracrine activation/autocrine activation in CAFs. The extracellular vesicles released by the CAFs are shown to play an important role in tumor progression and migration.,
The CAFs produce HGF, which activates the c-Met signaling in tumor cells and also increases IL-8 expression in them. They show increased expression of IL-1 βR, brain derived nuclear factor, Interferon Regulatory factor-1, IL-6 and Cox-2. All these result in tumor progression and metastasis. The CAFs express IL-1 β, MMP-1, 3 and 2 and membrane Type 1 MMPase. Amongst them, MMP-2 is associated with poor prognosis of OSCC. They enhance intratumoral microvessel density.,,
The CAFs also play an important role in lymphangiogenesis and angiogenesis. OSCCs stimulate NOTCH 3 expression in the stromal fibroblasts. The NOTCH positive fibroblasts induce angiogenesis by Human umbilical vein endothelial cell. CAFs regulate lymphangiogenesis through C-Met/PI3K/AKT signaling pathway. They secrete increased levels of HGF than normal oral fibroblasts. The HGFs produced promote proliferation, migration, invasion and tube formation of Human lymphatic endothelial cells, thereby enhancing lymphangiogenesis in OSCCs.,
The CAFs influence bone penetration of OSCCs through RANKL pathway. They induce the immunosuppressive and protumoral phenotype of tumor-associated macrophages.,
| Nickel Tolerance of Oral Tissues|| |
Oral tissues exhibit increased tolerance to nickel and show less hypersensitivity towards it than the skin. The possible reason could be the difference in the fibroblasts of both the tissues. Human gingival fibroblasts upon exposure to nickel ions show reduced expression pro-inflammatory NF-κB levels, IL-1 β mRNA and chemokine ligand-2; increase in anti-inflammatory IL-10 than human dermal fibroblasts. The dermal fibroblasts express very high VEGF m RNA levels, therefore increasing vascularization and endothelial permeability and immune cell invasion. Supernatants of dermal fibroblasts inhibit dendritic cell migration, while gingival fibroblasts increase dendritic cell migration. Therefore, the dermal fibroblasts promote proallergenic microenvironment and gingival fibroblasts favor protolerogenic anti-inflammatory microenvironment.
| Myofibroblasts|| |
Giulio Gabbiani and Hartroft, in 1971, first observed fibroblasts like cells, with abundant cytoplasmic filamentous structures and named as myofibroblasts. Myofibroblasts are spindle or stellate-shaped cells that possess bundles of microfilaments in their cytoplasm. They exhibit fibronexus junction between cells and extracellular matrix; focal adhesions and also gap junctions.
Myofibroblasts are present in both normal and disease. In the oral cavity, they are seen in the gingival, palatal mucosa and PDL. They are positive for α-SMA, vimentin, non-muscle myosin, desmin, smooth muscle myosin and extradomain A cellular fibronectin. The contraction of myofibroblasts is calcium mediated. The precursors for the myofibroblasts include fibroblasts, smooth muscle cells, pericytes, resident mesenchymal progenitor cells, adipose tissue cells, bone marrow derived circulating fibrocytes and mesenchymal stem cells. The malignant epithelial and endothelial cells also serve as a source for myofibroblasts through their epithelial to mesenchymal transition.
In normal wound healing, the myofibroblasts undergo apoptosis after the tissue integrity is restored. However, in case of hypertrophic scar, keloid, fibromatoses, TME, they escape the process of apoptosis and persist for a longer period. The survival of the myofibroblasts is influenced by TGF-β1 and endothelin-1 via the AKT pathway. In wound healing myofibroblasts present in the granulation tissue, synthesize and secrete the extracellular matrix that replaces the provisional matrix. Before evolving into a fully differentiated α-SMA positive myofibroblasts, they acquire the protomyofibroblasts phenotype expressing only β and γ cytoplasmic actins.
Increased number of myofibroblasts in salivary gland neoplasms such as adenoid cystic carcinoma and mucoepidermoid carcinoma indicates poor prognosis. These cells are present more in aggressive odontogenic cysts like odontogenic keratocyst than the less aggressive dentigerous cyst. In OSMF, increased myofibroblasts indicate a higher rate toward malignant transformation. In OSCC, the myofibroblasts play an important role in tumor angiogenesis, thereby contributing towards the spread of the tumor mass.,,
| Summary|| |
The fibroblasts are a diverse population of cells with various unique characteristics. They further exhibit unique features in the oral tissues that show differences in various processes than the skin. Their function in different oral tissue, wound healing, OSMF, OSCC and nickel allergy are summarized. Due to their uniqueness, oral fibroblasts can be used extensively in the future studies.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer 2016;16:582-98.
Baranyi U, Winter B, Gugerell A, Hegedus B, Brostjan C, Laufer G, et al.
Primary human fibroblasts in culture switch to a myofibroblast-like phenotype independently of TGF beta. Cells 2019;8:E721.
Zou ML, Teng YY, Wu JJ, Liu SY, Tang XY, Jia Y, et al.
Fibroblasts: Heterogeneous cells with potential in regenerative therapy for scarless wound healing. Front Cell Dev Biol 2021;9:713605.
Chiquet M, Katsaros C, Kletsas D. Multiple functions of gingival and mucoperiosteal fibroblasts in oral wound healing and repair. Periodontol 2000 2015;68:21-40.
Van Linthout S, Miteva K, Tschöpe C. Crosstalk between fibroblasts and inflammatory cells. Cardiovasc Res 2014;102:258-69.
Suvarna SK, Layton C, Bancroft JD. Bancroft's Theory and Practice of Histological Techniques. 7th
ed. Churchill Livingston: Elsevier; 2013.
Nancy A. Tencate's Oral Histology: Development, Structure and Function. 8th
ed. St.Louis, Missouri: Elsevier; 2013.
Baglole CJ, Reddy SY, Pollock SJ, Feldon SE, Sime PJ, Smith TJ, et al.
Isolation and phenotypic characterization of lung fibroblasts. Methods Mol Med 2005;117:115-27.
Agorku DJ, Langhammer A, Heider U, Wild S, Bosio A, Hardt O. CD49b, CD87, and CD95 are markers for activated cancer-associated fibroblasts whereas CD39 marks quiescent normal fibroblasts in murine tumor models. Front Oncol 2019;9:716.
Han C, Liu T, Yin R. Biomarkers for cancer-associated fibroblasts. Biomark Res 2020;8:64.
Denu RA, Nemcek S, Bloom DD, Goodrich AD, Kim J, Mosher DF, et al.
Fibroblasts and mesenchymal stromal/stem cells are phenotypically indistinguishable. Acta Haematol 2016;136:85-97.
Roy B, Yuan L, Lee Y, Bharti A, Mitra A, Shivashankar GV. Fibroblast rejuvenation by mechanical reprogramming and redifferentiation. Proc Natl Acad Sci U S A 2020;117:10131-41.
Nakanishi T, Takegawa D, Hirao K, Takahashi K, Yumoto H, Matsuo T. Roles of dental pulp fibroblasts in the recognition of bacterium-related factors and subsequent development of pulpitis. Japan Dent Sci Rev 2011;47:161-6.
Tran-Hung L, Mathieu S, About I. Role of human pulp fibroblasts in angiogenesis. J Dent Res 2006;85:819-23.
Chmilewsky F, Jeanneau C, Laurent P, About I. Pulp fibroblasts synthesize functional complement proteins involved in initiating dentin-pulp regeneration. Am J Pathol 2014;184:1991-2000.
Jeanneau C, Lundy FT, El Karim IA, About I. Potential therapeutic strategy of targeting pulp fibroblasts in dentin-pulp regeneration. J Endod 2017;43:S17-24.
Mi HW, Lee MC, Fu E, Chow LP, Lin CP. Highly efficient multipotent differentiation of human periodontal ligament fibroblasts induced by combined BMP4 and hTERT gene transfer. Gene Ther 2011;18:452-61.
Basdra EK, Komposch G. Osteoblast-like properties of human periodontal ligament cells: An in vitro
analysis. Eur J Orthod 1997;19:615-21.
Berahim Z, Moharamzadeh K, Jowett AK, Rawlinson A. Evaluation of osteogenic and cementogenic potential of periodontal ligament fibroblast spheroids using a three-dimensional in vitro
model of periodontium. Int J Dent 2015;2015:605813.
Nomura Y, Ishikawa M, Yashiro Y, Sanggarnjanavanich S, Yamaguchi T, Arai C, et al.
Human periodontal ligament fibroblasts are the optimal cell source for induced pluripotent stem cells. Histochem Cell Biol 2012;137:719-32.
Archana DA, Venkata Srikanth D, Sasireka D, Bobby Kurien D, Ebenezer D. Fibroblast heterogeneity in periodontium – A review. Int J Dent Sci Res 2014;2:50-4.
Pansani TN, Basso FG, Soares DG, Hebling J, Costa CA. Functional differences in gingival fibroblasts obtained from young and elderly individuals. Braz Dent J 2016;27:485-91.
Nguyen PA, Pham TAV. Effects of platelet-rich plasma on human gingival fibroblast proliferation and migration in vitro
. J Appl Oral Sci 2018;26:e20180077.
Lee HG, Eun HC. Differences between fibroblasts cultured from oral mucosa and normal skin: Implication to wound healing. J Dermatol Sci 1999;21:176-82.
Sloan P. Current concepts of the role of fibroblasts and extracellular matrix in wound healing and their relevance to oral implantology. J Dent 1991;19:107-9.
Miyoshi K, Horiguchi T, Tanimura A, Hagita H, Noma T. Gene signature of human oral mucosa fibroblasts: Comparison with dermal fibroblasts and induced pluripotent stem cells. Biomed Res Int 2015;2015:121575.
El Ghalbzouri A, Lamme E, Ponec M. Crucial role of fibroblasts in regulating epidermal morphogenesis. Cell Tissue Res 2002;310:189-99.
Maas-Szabowski N, Stark HJ, Fusenig NE. Keratinocyte growth regulation in defined organotypic cultures through IL-1-induced keratinocyte growth factor expression in resting fibroblasts. J Invest Dermatol 2000;114:1075-84.
Okazaki M, Yoshimura K, Uchida G, Harii K. Elevated expression of hepatocyte and keratinocyte growth factor in cultured buccal-mucosa-derived fibroblasts compared with normal-skin-derived fibroblasts. J Dermatol Sci 2002;30:108-15.
Sun DP, Yeh CH, So E, Wang LY, Wei TS, Chang MS, et al.
Interleukin (IL)-19 promoted skin wound healing by increasing fibroblast keratinocyte growth factor expression. Cytokine 2013;62:360-8.
Ahangar P, Mills SJ, Smith LE, Gronthos S, Cowin AJ. Human gingival fibroblast secretome accelerates wound healing through anti-inflammatory and pro-angiogenic mechanisms. NPJ Regen Med 2020;5:24.
Chaussain Miller C, Septier D, Bonnefoix M, Lecolle S, Lebreton-Decoster C, Coulomb B, et al.
Human dermal and gingival fibroblasts in a three-dimensional culture: A comparative study on matrix remodeling. Clin Oral Investig 2002;6:39-50.
Costea DE, Loro LL, Dimba EA, Vintermyr OK, Johannessen AC. Crucial effects of fibroblasts and keratinocyte growth factor on morphogenesis of reconstituted human oral epithelium. J Invest Dermatol 2003;121:1479-86.
Ivanovski S, Li H, Haase HR, Bartold PM. Expression of bone associated macromolecules by gingival and periodontal ligament fibroblasts. J Periodontal Res 2001;36:131-41.
de Sousa Gomes P, Daugela P, Poskevicius L, Mariano L, Fernandes MH. Molecular and cellular aspects of socket healing in the absence and presence of graft materials and autologous platelet concentrates: A focused review. J Oral Maxillofac Res 2019;10:e2.
Lin WL, McCulloch CA, Cho MI. Differentiation of periodontal ligament fibroblasts into osteoblasts during socket healing after tooth extraction in the rat. Anat Rec 1994;240:492-506.
Pierce GF, Mustoe TA, Altrock BW, Deuel TF, Thomason A. Role of platelet-derived growth factor in wound healing. J Cell Biochem 1991;45:319-26.
Patil R, Kale AD, Mane DR, Patil D. Determination of phenotypic alteration of arecolineinduced buccal mucosal fibroblasts: An in-vitro
cell culture study. Indian J Health Sci Biomed Res 2021;14:150-5. [Full text]
Chang YC, Lii CK, Tai KW, Chou MY. Adverse effects of arecoline and nicotine on human periodontal ligament fibroblasts in vitro
. J Clin Periodontol 2001;28:277-82.
Mathew DG, Skariah KS, Ranganathan K. Proliferative and morphologic characterization of buccal mucosal fibroblasts in areca nut chewers: A cell culture study. Indian J Dent Res 2011;22:879. [Full text]
Harvey W, Scutt A, Meghji S, Canniff JP. Stimulation of human buccal mucosa fibroblasts in vitro
by betel-nut alkaloids. Arch Oral Biol 1986;31:45-9.
Kuo MY, Chen HM, Hahn LJ, Hsieh CC, Chiang CP. Collagen biosynthesis in human oral submucous fibrosis fibroblast cultures. J Dent Res 1995;74:1783-8.
Pant I, Kumar N, Khan I, Rao SG, Kondaiah P. Role of areca nut induced TGF-β and epithelial-mesenchymal interaction in the pathogenesis of oral submucous fibrosis. PLoS One 2015;10:1-19.
Rai A, Ahmad T, Parveen S, Parveen S, Faizan MI, Ali S. Expression of transforming growth factor beta in oral submucous fibrosis. J Oral Biol Craniofac Res 2020;10:166-70.
Bishen KA, Radhakrishnan R, Satyamoorthy K. The role of basic fibroblast growth factor in oral submucous fibrosis pathogenesis. J Oral Pathol Med 2008;37:402-11.
Deng YT, Chen HM, Cheng SJ, Chiang CP, Kuo MY. Arecoline-stimulated connective tissue growth factor production in human buccal mucosal fibroblasts: Modulation by curcumin. Oral Oncol 2009;45:e99-105.
Angadi PV, Kale AD, Hallikerimath S. Evaluation of myofibroblasts in oral submucous fibrosis: Correlation with disease severity. J Oral Pathol Med 2011;40:208-13.
Rao KB, Malathi N, Narashiman S, Rajan ST. Evaluation of myofibroblasts by expression of alpha smooth muscle actin: A marker in fibrosis, dysplasia and carcinoma. J Clin Diagn Res 2014;8:C14-7.
Shieh DH, Chiang LC, Shieh TY. Augmented mRNA expression of tissue inhibitor of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and safrole as a possible pathogenesis for oral submucous fibrosis. Oral Oncol 2003;39:728-35.
Chang MC, Lin LD, Wu HL, Ho YS, Hsien HC, Wang TM, et al.
Areca nut-induced buccal mucosa fibroblast contraction and its signaling: A potential role in oral submucous fibrosis – A precancer condition. Carcinogenesis 2013;34:1096-104.
Liu T, Han C, Wang S, Fang P, Ma Z, Xu L, et al.
Cancer-associated fibroblasts: An emerging target of anti-cancer immunotherapy. J Hematol Oncol 2019;12:86.
Fullár A, Kovalszky I, Bitsche M, Romani A, Schartinger VH, Sprinzl GM, et al.
Tumor cell and carcinoma-associated fibroblast interaction regulates matrix metalloproteinases and their inhibitors in oral squamous cell carcinoma. Exp Cell Res 2012;318:1517-27.
Peltanova B, Raudenska M, Masarik M. Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: A systematic review. Mol Cancer 2019;18:63.
Guimaraes VS, Vidal MT, de Faro Valverde L, de Oliveira MG, de Oliveira Siquara da Rocha L, Coelho PL, et al.
Hedgehog pathway activation in oral squamous cell carcinoma: Cancer-associated fibroblasts exhibit nuclear GLI-1 localization. J Mol Histol 2020;51:675-84.
Li Y yin, Zhou CX, Gao Y. Interaction between oral squamous cell carcinoma cells and fibroblasts through TGF-β1 mediated by podoplanin. Exp Cell Res 2018;369:43-53.
Dourado MR, Korvala J, Åström P, De Oliveira CE, Cervigne NK, Mofatto LS, et al.
Extracellular vesicles derived from cancer-associated fibroblasts induce the migration and invasion of oral squamous cell carcinoma. J Extracell Vesicles 2019;8:1578525.
Prime SS, Cirillo N, Hassona Y, Lambert DW, Paterson IC, Mellone M, et al.
Fibroblast activation and senescence in oral cancer. J Oral Pathol Med 2017;46:82-8.
Knowles LM, Stabile LP, Egloff AM, Rothstein ME, Thomas SM, Gubish CT, et al.
HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancer. Clin Cancer Res 2009;15:3740-50.
Ueno T, Utsumi J, Toi M, Shimizu K. Characteristic gene expression profiles of human fibroblasts and breast cancer cells in a newly developed bilateral coculture system. Biomed Res Int 2015;2015:960840.
Dudás J, Fullár A, Bitsche M, Schartinger V, Kovalszky I, Sprinzl GM, et al.
Tumor-produced, active Interleukin-1 β regulates gene expression in carcinoma-associated fibroblasts. Exp Cell Res 2011;317:2222-9.
Rosenthal EL, McCrory A, Talbert M, Carroll W, Magnuson JS, Peters GE. Expression of proteolytic enzymes in head and neck cancer-associated fibroblasts. Arch Otolaryngol Head Neck Surg 2004;130:943-7.
Kayamori K, Katsube KI, Sakamoto K, Ohyama Y, Hirai H, Yukimori A, et al
. Notch3 is induced in cancer-associated fibroblasts and promotes angiogenesis in oral squamous cell carcinoma PLoS One 2016;11:1-19.
Gao P, Li C, Chang Z, Wang X, Xuan M. Carcinoma associated fibroblasts derived from oral squamous cell carcinoma promote lymphangiogenesis via c-Met/PI3K/AKT in vitro
. Oncol Lett 2018;15:331-7.
Elmusrati AA, Pilborough AE, Khurram SA, Lambert DW. Cancer-associated fibroblasts promote bone invasion in oral squamous cell carcinoma. Br J Cancer 2017;117:867-75.
Takahashi H, Sakakura K, Kudo T, Toyoda M, Kaira K, Oyama T, et al.
Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages. Oncotarget 2017;8:8633-47.
Gölz L, Vestewig E, Blankart M, Kraus D, Appel T, Frede S, et al.
Differences in human gingival and dermal fibroblasts may contribute to oral-induced tolerance against nickel. J Allergy Clin Immunol 2016;138:1202-5.e3.
Darby IA, Laverdet B, Bonté F, Desmoulière A. Fibroblasts and myofibroblasts in wound healing. Clin Cosmet Investig Dermatol 2014;7:301-11.
Hinz B. The role of myofibroblasts in wound healing. Curr Res Transl Med 2016;64:171-7.
Biswal BN, Das SN, Das BK, Rath R. Alteration of cellular metabolism in cancer cells and its therapeutic prospects. J Oral Maxillofac Pathol 2017;21:244-51.
] [Full text]